| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.24 | 7e-12 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-09 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-05 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.23 | 7e-05 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |